The current study was randomized, double blind, placebo-controlled, prospective, multicenter,
comparative therapeutic equivalence study.
The study duration for each patient was 6 weeks: Following were the visit details.
V1-Baseline and Randomization Visit (Day 1). V2- End of therapy visit (at the end of week 2 +
2 days). V3- Follow up visit (at the end of week 4 + 2 days). V4 - Test of cure visit ( at
the end of week 6 + 4 days).
Phase:
Phase 3
Details
Lead Sponsor:
Genzum Life Sciences Semler Research Center Pvt. Ltd.